Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
NCT06237712 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2025-08-12
Summary
With this research the investigators want to study how patients with chronic kidney disease respond to different sodium- and potassium salts. Potassium salts can prevent kidney damage and cardiovascular disease, however patients with chronic kidney disease can responds differently. Extra potassium can increase the amount of potassium in the blood and extra chloride can cause acidosis. With this study the investigators will gain more insight in how patients with chronic kidney disease respond to sodium and potassium salts and which one is more favorable.This information can then be used to guide the application of salt substitutes and dietary adjustments in patients with chronic kidney disease.
Conditions
- Metabolic Acidosis
- CKD
- Electrolyte and Fluid Balance Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Dietary supplement consisting of 40 mmol/daily of potassium chloride
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
- DIETARY_SUPPLEMENT
-
Dietary supplement consisting of 40 mmol/daily of potassium gluconate
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
- DIETARY_SUPPLEMENT
-
Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
- DIETARY_SUPPLEMENT
-
Dietary supplement consisting of 40 mmol/daily of sodium chloride
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
- DIETARY_SUPPLEMENT
-
Dietary supplement consisting of 40 mmol/daily of sodium bicarbonate
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
- DIETARY_SUPPLEMENT
-
Placebo caps
The supplements are delivered in plain vegetable 00 caps, stabelizing additives are potatostarch, sunflower lecithine and sunflower oil. The capsuels are free of titanium oxide and suited for human consumption.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-26
- Primary Completion
- 2025-03-21
- Completion
- 2026-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial
NCT00974636 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
NCT07231900 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)
NCT02692378 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
NCT05056727 ·Status: TERMINATED ·Phase: PHASE3
-
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
NCT06545461 ·Status: COMPLETED ·Phase: NA
-
Potassium Intake in Patients With Chronic Kidney Disease
NCT00949585 ·Status: COMPLETED ·Phase: NA
-
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS
NCT07178964 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)
NCT01640119 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
NCT03528681 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
NCT00004328 ·Status: COMPLETED ·Phase: PHASE2
-
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4
NCT06365684 ·Status: RECRUITING ·Phase: PHASE4
-
Tissue K+ in Primary Hyperaldosteronism
NCT04251780 ·Status: COMPLETED
-
The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT01414088 ·Status: COMPLETED ·Phase: NA
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction
NCT00575484 ·Status: TERMINATED ·Phase: PHASE2
-
Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
NCT00384384 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
NCT02665117 ·Status: COMPLETED ·Phase: NA
-
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
NCT02046135 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074
NCT02228733 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure
NCT02031354 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
NCT02653014 ·Status: COMPLETED ·Phase: PHASE1
-
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
NCT06736184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
NCT04530448 ·Status: TERMINATED ·Phase: PHASE4
-
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
NCT03283267 ·Status: COMPLETED ·Phase: PHASE1